Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple shield keep IVs in place longer for cancer patients?

NCT ID NCT06675786

Disease control Sponsor: Karamanoğlu Mehmetbey University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This trial tests whether a special catheter protector, called I.V. House UltraDressing, can help peripheral IV catheters stay in place longer and cause fewer complications in adult cancer patients. Participants are randomly assigned to receive either the standard transparent dressing or the standard dressing plus the protector. The study tracks how long the catheter remains functional and monitors for issues like irritation, blockage, or leakage.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
I.V. House UltraDressing, a catheter protector device
What this could lead to
If effective, this device could reduce painful IV complications and the need for repeated needle sticks in cancer patients.
What could go wrong
This is a small, early-stage study, so results may not apply broadly. The device may not significantly improve dwell time or complication rates.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

69 people

The number who actually took part.

Started

Oct 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Inclusion Criteria * Hospitalized in the oncology clinic * The one with the PVK attached, * Volunteered to participate in the research, * Treated in the same clinic during the study period, * No verbal, perceptual and visual communication problems, * 22-24 G (Blue) size catheter used, * Between the ages of 18 and 65, * Literate, -- Patients without scar tissue, infection, hematoma, edema at the sites to be used for PVK placement and successful PIVC placement on their first attemptwere included in the study. Exculision Criteria: * \- With a clotting disorder, * Patients with problems with skin integrity or limb movement such as scar tissue, infection, hematoma, edema at the PVK site, * Blood or blood products given through a catheter, * Patients who wanted to leave, were referred to a different clinic or discharged during the study were excluded from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Complications are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

phlebitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Complications Peripheral catheterization

Contacts and locations

Locations

  • Necmettin Erbakan University

    Konya, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.